Liquid Biopsy Assay Shows Superior Sensitivity in Head-to-Head Study
The assay detected 51% more pathogenic variants and 109% more copy number variants compared to six commercial liquid biopsy assays in prospective validation study.
Category: Sequencing Systems
Sequencing Systems
Latest
Sequencing Systems
Latest
How NGS-Based MRD Is Reshaping Hematological Malignancy Management
NGS-based MRD testing offers unprecedented sensitivity and breadth in detecting low-frequency leukemic clones.
Sequencing Systems
Latest
Metabolite Detection Method Using DNA Sequencing Invented
Researchers have developed a revolutionary method using DNA sequencing to rapidly and precisely measure metabolites critical for health.
Delve Bio Launches Genomic Infectious Disease Test Delve Detect
Delve Bio’s Delve Detect is a metagenomic sequencing test capable of quickly identifying over 68,000 pathogens from CSF.
Read More
Genomic Test Rapidly Identifies Pathogens Behind Neurological and Respiratory Infections
A mNGS test offers a rapid, comprehensive solution to diagnose a broad range of pathogens in neurological and respiratory infections.
Read More
How Systemic Barriers Cause Racial Disparities in Genetic Diagnosis
A study reveals that while diagnostic accuracy in genetic testing is consistent across racial groups, access disparities persist.
Read More
Biotia’s Genomics-Based Urine Test Gains New York State Approval
Biotia’s BIOTIA-ID Urine NGS Assay uses artificial intelligence (AI) and genomics to deliver rapid, highly accurate UTI diagnoses.
Read More
Illumina Launches New Series of Benchtop Sequencing Systems
Illumina’s new MiSeq i100 Series sequencing systems provide faster, simpler, and more cost-efficient next-generation sequencing solutions.
Read More
Healthcare-Associated Infections Can Be Reduced with DNA Sequencing
Reducing the incidence of healthcare-associated infections, and the antimicrobial resistance they can trigger, is critical for patient care.
Read More
NeoGenomics Launches New Sequencing Assay for Rapid Genetic Profiling of AML
The next-generation sequencing assay delivers rapid and comprehensive genetic profiling for AML patients, guiding precise treatment decisions.
Read More
Breakthroughs in Diagnosing Colorectal Cancer with Rare Genetic Variants
A new study emphasizes the potential of advanced sequencing techniques in improving outcomes for CRC patients with rare genetic variants.
Read More
Ambry Genetics Announces New Multiomic Exome Test for Improved Rare Disease Detection
Ambry Genetics unveiled a new multiomic exome sequencing test that incorporates RNA analysis to enhance the detection of rare diseases.
Read More
GeneDx Announces Whole Genome Sequencing Product Enhancements to Accelerate Diagnoses
GeneDx announced enhancements to its whole genome sequencing services, all aimed at accelerating diagnoses and improving health outcomes.
Read More
Baylor Genetics and Baylor College of Medicine Launch New Lab
Baylor Genetics and Baylor College of Medicine have launched the Medical Genetics Multi-Omics Laboratory to innovate genetic testing.
Read More
Unlock Behind the Seizure Program Provides Testing for Pediatric Epilepsy
The Unlock Behind the Seizure program aims to provide accessible and affordable genetic testing for pediatric epilepsy patients.
Read More
Whole Genome Sequencing Improves Pediatric Cancer Care
Whole genome sequencing has improved care for some children with cancer in England and can potentially replace multiple standard tests.
Read More
Rapid Cerebrospinal Fluid Test Decreases Time for Brain Tumors Diagnosis
A new genotyping test using cerebrospinal fluid can rapidly diagnose brain cancers, reducing the need for invasive biopsies.
Read More
Foundation Medicine Launches RNA Sequencing Test
Foundation Medicine launched a tissue-based RNA sequencing test in the U.S. for the detection of cancer-related fusions across 318 genes.Â
Read More